 Your new post is loading...
 Your new post is loading...
|
Scooped by
Gerd Moe-Behrens
March 31, 2012 9:21 AM
|
by Martin Dragosits, Daniel Nicklas and Ilias Tagkopoulos "Background Recombinant protein production is a process of great industrial interest, with products that range from pharmaceuticals to biofuels. Since high level production of recombinant protein imposes significant stress in the host organism, several methods have been developed over the years to optimize protein production. So far, these trial-and-error techniques have proved laborious and sensitive to process parameters, while there has been no attempt to address the problem by applying Synthetic Biology principles and methods, such as integration of standardized parts in novel synthetic circuits. Results We present a novel self-regulatory protein production system that couples the control of recombinant protein production with a stress-induced, negative feedback mechanism. The synthetic circuit allows the down-regulation of recombinant protein expression through a stress-induced promoter. We used E. coli as the host organism, since it is widely used in recombinant processes. Our results show that the introduction of the self-regulatory circuit increases the soluble/insoluble ratio of recombinant protein at the expense of total protein yield. To further elucidate the dynamics of the system, we developed a computational model that is in agreement with the observed experimental data, and provides insight on the interplay between protein solubility and yield. Conclusion Our work introduces the idea of a self-regulatory circuit for recombinant protein products, and paves the way for processes with reduced external control or monitoring needs. It demonstrates that the library of standard biological parts serves as a valuable resource for initial synthetic blocks that needs to be further refined to be successfully applied in practical problems of biotechnological significance. Finally, the development of a predictive model in conjunction with experimental validation facilitates a better understanding of the underlying dynamics and can be used as a guide to experimental design...."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 7:23 PM
|
"A hidden, never-before-recognized layer of information in the genetic code has been uncovered by a team of scientists at the University of California, San Francisco (UCSF) thanks to a technique developed at UCSF called ribosome profiling, which enables the measurement of gene activity inside living cells — including the speed with which proteins are made. By measuring the rate of protein production in bacteria, the team discovered that slight genetic alterations could have a dramatic effect. This was true even for seemingly insignificant genetic changes known as “silent mutations,” which swap out a single DNA letter without changing the ultimate gene product. To their surprise, the scientists found these changes can slow the protein production process to one-tenth of its normal speed or less..."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 6:13 PM
|
do we? "Recent developments in synthetic biology are described and characterized as moving the era of biotechnology into platform technologies. Platform technologies enable rapid and diffuse innovations and simultaneous product development in diffuse markets, often targeting sectors of the economy that have traditionally been thought to have little relationship to one another. In the case of synthetic biology, pharmaceutical and biofuel product development are occurring interactively. But the regulatory and ethical issues associated with these two applications share very little overlap. As such, there is some risk that focus on traditional medical applications, for which the ethical expertise is highly developed, will overshadow the ethical issues that arise in connection with land use and its attendant socioeconomic consequences, especially in the developing world. The 2010 report of the Presidential Commission for the Study of Bioethics exhibits this tendency."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 4:44 PM
|
About the promises and potential perils of synthetic biology, with Vincent Martin and Tania Bubela (0:00) (Facchini et al. and Bubela et al.)
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 4:29 PM
|
A tiny prototype robot that functions like a living creature is being developed that one day could be safely used to pinpoint diseases within the human...
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 3:58 PM
|
by Han Li, Paul H. Opgenorth, David G. Wernick, Steve Rogers, Tung-Yun Wu, Wendy Higashide, Peter Malati, Yi-Xin Huo, Kwang Myung Cho, James C. Liao "One of the major challenges in using electrical energy is the efficiency in its storage. Current methods, such as chemical batteries, hydraulic pumping, and water splitting, suffer from low energy density or incompatibility with current transportation infrastructure. Here, we report a method to store electrical energy as chemical energy in higher alcohols, which can be used as liquid transportation fuels. We genetically engineered a lithoautotrophic microorganism, Ralstonia eutropha H16, to produce isobutanol and 3-methyl-1-butanol in an electro-bioreactor using CO2 as the sole carbon source and electricity as the sole energy input. The process integrates electrochemical formate production and biological CO2 fixation and higher alcohol synthesis, opening the possibility of electricity-driven bioconversion of CO2 to commercial chemicals...."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 7:05 AM
|
"In the not-too-distant future, plastic chips the size of flash cards may quickly and accurately diagnose diseases such as AIDS and cancer, as well as detect toxins and pathogens in the environment. Such lab-on-a-chip technology — known as microfluidics — works by flowing fluid such as blood through microscopic channels etched into a polymer’s surface. Scientists have devised ways to manipulate the flow at micro- and nanoscales to detect certain molecules or markers that signal disease."
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 7:01 PM
|
A tiny prototype robot that functions like a living creature is being developed which one day could be safely used to pinpoint diseases within the human body.
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 6:16 PM
|
"If someone had told me ten years ago that there would be a single website that the public would visit for information about science and technology, I would have laughed at them. The very notion seems the antithesis of the anarchic disorganised web. If they had then told me that I, and anyone with an internet connection, would be able to edit that website, I would have thought they had seriously lost the plot. But ten years after the birth of Wikipedia, this is exactly what we have. If you want to know what a zedonk looks like, the chances are your search engine will point you first to Wikipedia. What most scientists have yet to realise is that Wikipedia offers a huge opportunity for engaging with the public and explaining their science. As a scientist, I want the public to understand my research and why it is important. After all, it's usually their taxes paying for it. This public engagement traditionally involves giving a lecture at a science festival or talking to classes of children. I think that this is preaching to the converted. At best I might lecture to 100 people at a time. However, if I write or edit a Wikipedia article, my potential audience is some of Wikipedia's 365 million readers worldwide. Even if only a small fraction of these are interested in knowing what a genome is, it's still a pretty large number of people. The genome article in Wikipedia was viewed over half a million times last year......"
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 5:31 PM
|
by Jarred M. Callura, Charles R. Cantorb, and James J. Collins "A key next step in synthetic biology is to combine simple circuits into higher-order systems. In this work, we expanded our synthetic riboregulation platform into a genetic switchboard that independently controls the expression of multiple genes in parallel. First, we designed and characterized riboregulator variants to complete the foundation of the genetic switchboard; then we constructed the switchboard sensor, a testing platform that reported on quorum-signaling molecules, DNA damage, iron starvation, and extracellular magnesium concentration in single cells. As a demonstration of the biotechnological potential of our synthetic device, we built a metabolism switchboard that regulated four metabolic genes, pgi, zwf, edd, and gnd, to control carbon flow through three Escherichia coli glucose-utilization pathways: the Embden–Meyerhof, Entner–Doudoroff, and pentose phosphate pathways. We provide direct evidence for switchboard-mediated shunting of metabolic flux by measuring mRNA levels of the riboregulated genes, shifts in the activities of the relevant enzymes and pathways, and targeted changes to the E. coli metabolome. The design, testing, and implementation of the genetic switchboard illustrate the successful construction of a higher-order system that can be used for a broad range of practical applications in synthetic biology and biotechnology...."
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 6:58 AM
|
Please sign! WE PETITION THE OBAMA ADMINISTRATION TO: Increase NIH funding to $33 billion! The proposed flat $30.7 billion dollars will hurt the econmy and medical research!
|
Scooped by
Gerd Moe-Behrens
March 28, 2012 4:47 PM
|
The preeminent meeting in Synthetic Biology, covering biotechnologies, biosafety, biosecurity & bioethics, July 9-11, 2013 at Imperial College in London UK.
|
Scooped by
Gerd Moe-Behrens
March 28, 2012 11:02 AM
|
"Last post I mentioned an interesting research introducing RNA interfere system in bacterium and archaea. It gives a new sight into how similarities the three kingdoms share, and potentially what have been done in mammalian cells can be applied into E.coli to enrich the toolbox of synthetic biologists. Today let’s take a glimpse at what is on earth the progress in mammalian synthetic biology world. Is the bio-system as feasible to engineer as E.coli, just like iGEM? Is the field quite matured enough? Or still long way to go?..."
|
|
Scooped by
Gerd Moe-Behrens
March 31, 2012 9:17 AM
|
"Recombinant protein production is a process of great industrial interest, with products that range from pharmaceuticals to biofuels. Since high level production of recombinant protein imposes significant stress in the host organism, several methods have been developed over the years to optimize protein production. So far, these trial-and-error techniques have proved laborious and sensitive to process parameters, while there has been no attempt to address the problem by applying Synthetic Biology principles and methods, such as integration of standardized parts in novel synthetic circuits. Results: We present a novel self-regulatory protein production system that couples the control of recombinant protein production with a stress-induced, negative feedback mechanism. The synthetic circuit allows the down-regulation of recombinant protein expression through a stress-induced promoter...."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 6:23 PM
|
"Paul Thompson argues that current synthetic biology amounts to synthetic genomics, comprising a ‘platform’ technology, and that Christopher Preston's deontological objections based on its supposed rejection of the historical process of evolution miscarry. This makes it surprising that Thompson's normative ethic consists in a deontological appeal to Kantian duties of imperfect obligation. Construed as obligations subject to choice, such constraints risk being excessively malleable where the ethical objections to deployment of this technology concern land rights and/or exploitation. Thompson's advocacy of processes ‘more beneficial’ (to poor people) well illustrates another vulnerability; processes more beneficial than ones that undermine livelihoods could be best avoided themselves, although ones more beneficial than the status quo may not. He well argues that non-deontological arguments should not be confined to human survival, but neglects stances that are either biocentric, consequentialist, or both. Yet a truly synthetic bioethics would be likely to embody these characteristics."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 5:29 PM
|
"Wikidata, the first new project to emerge from the Wikimedia Foundation since 2006, is now beginning development. The organization, known best for its user-edited encyclopedia of knowledge Wikipedia, recently announced the new project at February’s Semantic Tech & Business Conference in Berlin, describing Wikidata as new effort to provide a database of knowledge that can be read and edited by humans and machines alike. There have been other attempts at creating a semantic database built from Wikipedia’s data before – for example, DBpedia, a community effort to extract structured content from Wikipedia and make it available online. The difference is that, with Wikidata, the data won’t just be made available, it will also be made editable by anyone. The project’s goal in developing a semantic, machine-readable database doesn’t just help push the web forward, it also helps Wikipedia itself. The data will bring all the localized versions of Wikipedia on par with each other in terms of the basic facts they house. Today, the English, German, French and Dutch versions offer the most coverage, with other languages falling much further behind. Wikidata will also enable users to ask different types of questions, like which of the world’s ten largest cities have a female mayor?, for example. Queries like this are today answered by user-created Wikipedia Lists – that is, manually created structured answers. Wikidata, on the hand, will be able to create these lists automatically...."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 4:36 PM
|
by Tania Bubela, Gregory Hagen, Edna Einsiedel "The novelty of synthetic biology lies in the use of synthesized parts that can be arranged to make useful products. Such advanced, high-throughput genetic engineering projects redesign and fabricate existing biological systems as well as new biological parts, devices and systems that do not occur in nature. This Opinion discusses challenges raised by synthetic biology for public acceptance, regulation, commercialization and the emerging global issue of access to genetic resources and information. As with all new fields of research, maintaining the trust of the public and policy regulators is paramount. Hype and exaggerated claims are counterproductive to developing adaptive and ethically sound regulatory models responsive to stakeholder concerns."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 4:23 PM
|
by Peter J. Facchini, Joerg Bohlmann, Patrick S. Covello, Vincenzo De Luca, Radhakrishnan Mahadevan, Jonathan E. Page, Dae-Kyun Ro, Christoph W. Sensen, Reginald Storms, Vincent J.J. Martin "Plants display an immense diversity of specialized metabolites, many of which have been important to humanity as medicines, flavors, fragrances, pigments, insecticides and other fine chemicals. Apparently, much of the variation in plant specialized metabolism evolved through events of gene duplications followed by neo- or sub-functionalization. Most of the catalytic diversity of plant enzymes is unexplored since previous biochemical and genomics efforts have focused on a relatively small number of species. Interdisciplinary research in plant genomics, microbial engineering and synthetic biology provides an opportunity to accelerate the discovery of new enzymes. The massive identification, characterization and cataloguing of plant enzymes coupled with their deployment in metabolically optimized microbes provide a high-throughput functional genomics tool and a novel strain engineering pipeline."
|
Scooped by
Gerd Moe-Behrens
March 30, 2012 11:50 AM
|
"Recombinant protein production is a process of great industrial interest, with products that range from pharmaceuticals to biofuels. Since high level production of recombinant protein imposes significant stress in the host organism, several methods have been developed over the years to optimize protein production. So far, these trial-and-error techniques have proved laborious and sensitive to process parameters, while there has been no attempt to address the problem by applying Synthetic Biology principles and methods, such as integration of standardized parts in novel synthetic circuits...." Results: We present a novel self-regulatory protein production system that couples the control of recombinant protein production with a stress-induced, negative feedback mechanism. The synthetic circuit allows the down-regulation of recombinant protein expression through a stress-induced promoter.
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 7:31 PM
|
This group is designed to provide a feed of breaking news on the subject of synthetic biology with room to discuss the news with those in the know. (RT @GlennMiles2012Info sharing group on LinkedIn on the subject of synthetic biology.
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 6:55 PM
|
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 5:45 PM
|
by Takezawa Y, Shionoya M. "With its capacity to store and transfer the genetic information within a sequence of monomers, DNA forms its central role in chemical evolution through replication and amplification. This elegant behavior is largely based on highly specific molecular recognition between nucleobases through the specific hydrogen bonds in the Watson-Crick base pairing system. While the native base pairs have been amazingly sophisticated through the long history of evolution, synthetic chemists have devoted considerable efforts to create alternative base pairing systems in recent decades. Most of these new systems were designed based on the shape complementarity of the pairs or the rearrangement of hydrogen-bonding patterns. We wondered whether metal coordination could serve as an alternative driving force for DNA base pairing and why hydrogen bonding was selected on Earth in the course of molecular evolution. Therefore, we envisioned an alternative design strategy: we replaced hydrogen bonding with another important scheme in biological systems, metal-coordination bonding. In this Account, we provide an overview of the chemistry of metal-mediated base pairing including basic concepts, molecular design, characteristic structures and properties, and possible applications of DNA-based molecular systems. We describe several examples of artificial metal-mediated base pairs, such as Cu(2+)-mediated hydroxypyridone base pair, H-Cu(2+)-H (where H denotes a hydroxypyridone-bearing nucleoside), developed by us and other researchers. To design the metallo-base pairs we carefully chose appropriate combinations of ligand-bearing nucleosides and metal ions. As expected from their stronger bonding through metal coordination, DNA duplexes possessing metallo-base pairs exhibited higher thermal stability than natural hydrogen-bonded DNAs. Furthermore, we could also use metal-mediated base pairs to construct or induce other high-order structures. These features could lead to metal-responsive functional DNA molecules such as artificial DNAzymes and DNA machines. In addition, the metallo-base pairing system is a powerful tool for the construction of homogeneous and heterogeneous metal arrays, which can lead to DNA-based nanomaterials such as electronic wires and magnetic devices. Recently researchers have investigated these systems as enzyme replacements, which may offer an additional contribution to chemical biology and synthetic biology through the expansion of the genetic alphabet."
|
Scooped by
Gerd Moe-Behrens
March 29, 2012 12:21 PM
|
by Ryan E. Cobba, Ning Sunc, Huimin Zhao "At the heart of synthetic biology lies the goal of rationally engineering a complete biological system to achieve a specific objective, such as bioremediation and synthesis of a valuable drug, chemical, or biofuel molecule. However, the inherent complexity of natural biological systems has heretofore precluded generalized application of this approach. Directed evolution, a process which mimics Darwinian selection on a laboratory scale, has allowed significant strides to be made in the field of synthetic biology by allowing rapid identification of desired properties from large libraries of variants. Improvement in biocatalyst activity and stability, engineering of biosynthetic pathways, tuning of functional regulatory systems and logic circuits, and development of desired complex phenotypes in industrial host organisms have all been achieved by way of directed evolution. Here, we review recent contributions of directed evolution to synthetic biology at the protein, pathway, network, and whole cell levels."
|
Scooped by
Gerd Moe-Behrens
March 28, 2012 5:05 PM
|
The Basic Idea "Money for Wonder and Amazement. Science Bucks will raise money over the internet for science research projects in the form of donations. In return, the researcher commits to tell their story of exploration and discovery on the company’s website which is open to the public. These stories will attract an increasingly larger audience to read about work on the frontiers of science and that growing audience will form a larger pool of prospective donators."
|
Scooped by
Gerd Moe-Behrens
March 28, 2012 2:58 PM
|
"DNA2.0 today introduced the GPS Bioengineering Platform: GeneGPS™, GenomeGPS™ and ProteinGPS™-a suite of proprietary technologies for engineering optimized genes, genomes and proteins. The company also announced the issuance of US patent 8,126,653 "Synthetic Nucleic Acids for Expression of Encoded Proteins." This is the third patent supporting the GeneGPS technology, which uses heuristics and systematic variance in combination with efficient gene synthesis to control and maximize recombinant protein expression in any host...."
|